Company intelligence / Profile preview

Agulos Biotech

Lake Mills, Wisconsin, United Statesagulosbiotech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Agulos Biotech produces SimPL Serum, a platelet lysate-based growth media supplement that matches or exceeds the performance of fetal bovine serum in cell culture applications. The product supports accelerated mammalian cell growth and has been validated to be free from adventitious agents per regulatory standards. It serves both industrial and academic users seeking cost-effective alternatives to FBS. No clinical results as it does not develop therapeutics.

Modalities: Media supplement (platelet lysate)Growth factor-rich media supplementCell culture reagents
Industry: Non-Drug Biotech

Partnerships

Johnsonville Foods (joint venture/strategic supply partnership)

Beyond the preview

Go deeper on Agulos Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agulos Biotech.

Explore the full profile